产品编号 :
Cas No. :
CAS No. |
2097129-93-4 |
|---|---|
中文名称 |
拉罗替尼甲磺酸盐水合物 |
英文名称 |
Larotinib mesylate hydrate |
别名 |
Larotinib mesylate hydrate;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-6-[3-[(4aR,7aS)-hexahydro-6H-1,4-dioxino[2,3-c]pyrrol-6-yl]propoxy]-7-methoxy-, rel-, methanesulfonate, hydrate (2:4:1) |
标准英文名 |
N-(3-chloro-4-fluorophenyl)-6-(3-((4aR,7aS)-hexahydro-6H-[1,4]dioxino[2,3-c]pyrrol-6-yl)propoxy)-7-methoxyquinazolin-4-amine methanesulfonate hydrate |
分子式 |
C25H32ClFN4O8S |
分子量 |
603.07 |
精确分子量 |
602.16 |
SMILES |
COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1C[C@@H]2OCCO[C@@H]2C1.CS(=O)(=O)O.O |
标准SMILES |
O.COC1=CC2=NC=NC(NC3C=C(Cl)C(F)=CC=3)=C2C=C1OCCCN1C[C@@H]2OCCO[C@@H]2C1.CS(O)(=O)=O |
用途 |
Larotinib mesylate hydrate is a potent, broad-spectrum, orally active tyrosine kinase inhibitor (TKI) targeting EGFR with an IC50 of 0.6 nM. |
InChIKey |
GHXANWVCYKSDDJ-AJFFIPFFSA-N |
|
|
评论 |
|---|